Jessica Fye Analyst PerformanceManaging Director, Equity Research Analyst - Biotechnology at JPMorgan Chase & Co.Jessica Fye is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 31 publicly traded companies. Over the past year, Jessica Fye has issued 45 stock ratings, including buy, hold, and sell recommendations. While full access to Jessica Fye's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jessica Fye's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings114 Last 11 YearsBuy Recommendations59.09% 65 Buy RatingsCompanies Covered31 Unique Companies Ratings Distribution110RatingsDistribution of strong buy, buy, hold, and sell ratings by Jessica Fye.RatingPercentageCount Strong Buy0.0%0 ratings Buy59.1%65 ratings Hold35.5%39 ratings Sell5.5%6 ratingsOut of 110 total stock ratings issued by Jessica Fye at JPMorgan Chase & Co., the majority (59.1%) have been Buy recommendations, followed by 35.5% Hold and 5.5% Sell.Best & Worst CallsBest Call0000.0%NKTRMar 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ESPRSep 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.8% of companies on NASDAQ30 companiesNYSE3.2% of companies on NYSE1 companyJessica Fye, an analyst at JPMorgan Chase & Co., currently covers 31 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare31 companies100.0%Jessica Fye of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY23 companies74.2%PHARMACEUTICALS7 companies22.6%HEALTHCARE EQUIPMENT & SUPPLIES1 company3.2% Jessica Fye's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsALNYAlnylam Pharmaceuticals9/30/2026Lower Price Target$251.00$369.00Overweight$0.0000.00% ROIBCRXBioCryst Pharmaceuticals9/30/2026Boost Price Target$8.38$13.00Neutral$0.0000.00% ROIINCYIncyte9/28/2026Boost Price Target$123.97$123.00Neutral$0.0000.00% ROIIONSIonis Pharmaceuticals9/22/2026Lower Price Target$44.90$70.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals9/11/2026Reiterated Rating$514.56$560.00Overweight$0.0000.00% ROISTOKStoke Therapeutics8/21/2026Initiated Coverage$31.76$40.00Overweight$0.0000.00% ROINKTRNektar Therapeutics8/21/2026Initiated Coverage$75.11$65.00Neutral$0.0000.00% ROIMBXMBX Biosciences8/21/2026Initiated Coverage$66.14$88.00Overweight$0.0000.00% ROIIMCRImmunocore8/21/2026Initiated Coverage$36.02$50.00Overweight$0.0000.00% ROIEBSEmergent Biosolutions8/21/2026Initiated Coverage$4.94Underweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AMRNAmarin8/21/2026Initiated Coverage$14.13$13.00Underweight$0.0000.00% ROIMRNAModerna8/21/2026Boost Price Target$147.13$77.00Underweight$0.0000.00% ROIINSMInsmed8/10/2026Lower Price Target$135.31$175.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals8/4/2026Boost Price Target$260.52$276.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals8/3/2026Boost Price Target$53.25$76.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/31/2026Lower Price Target$203.09$375.00Overweight$0.0000.00% ROIALKSAlkermes7/29/2026Boost Price Target$48.32$61.00Neutral$0.0000.00% ROIINCYIncyte7/23/2026Boost Price Target$116.08$110.00Neutral$0.0000.00% ROIONCBeOne Medicines7/23/2026Boost Price Target$328.12$425.00Overweight$0.0000.00% ROIUTHRUnited Therapeutics7/23/2026Boost Price Target$529.39$687.00Overweight$0.0000.00% ROIALNYAlnylam Pharmaceuticals7/22/2026Lower Price Target$268.29$400.00Overweight$0.0000.00% ROIAKTSAktis Oncology7/14/2026Boost Price Target$26.44$33.00Overweight$0.0000.00% ROINVCRNovoCure7/13/2026Initiated Coverage$16.30$17.00Neutral$0.0000.00% ROIBCRXBioCryst Pharmaceuticals7/13/2026Initiated Coverage$10.45$12.00Neutral$0.0000.00% ROIDNLIDenali Therapeutics7/13/2026Initiated Coverage$25.68$29.00Overweight$0.0000.00% ROILEGNLegend Biotech7/13/2026Initiated Coverage$27.08$35.00Neutral$0.0000.00% ROIALKSAlkermes7/13/2026Initiated Coverage$51.94$60.00Neutral$0.0000.00% ROIMIRMMirum Pharmaceuticals7/2/2026Boost Price Target$123.89$125.00Overweight$0.0000.00% ROIINSMInsmed6/8/2026Lower Price Target$94.22$179.00Overweight$0.0000.00% ROIAKTSAktis Oncology2/3/2026Initiated Coverage$21.98$30.00Overweight$0.0000.00% ROIDNLIDenali Therapeutics11/4/2025Boost Price Target$15.22$26.00Overweight$0.0000.00% ROISTOKStoke Therapeutics11/3/2025Boost Price Target$25.40$25.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics10/27/2025Boost Price Target$66.18$65.00Neutral$0.0000.00% ROINVCRNovoCure10/27/2025Lower Price Target$13.73$23.00Neutral$0.0000.00% ROIJAZZJazz Pharmaceuticals10/27/2025Lower Price Target$137.08$199.00Overweight$0.0000.00% ROIMRNAModerna10/23/2025Lower Price Target$26.18$25.00Underweight$0.0000.00% ROIBNTXBioNTech10/23/2025Lower Price Target$104.60$120.00Neutral$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/13/2025Lower Price Target$459.08$473.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/9/2025Boost Price Target$54.69$119.00Overweight$0.0000.00% ROIASNDAscendis Pharma A/S10/9/2025Boost Price Target$210.13$264.00Overweight$0.0000.00% ROITrump's New Dollar (Ad)Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.Watch the free briefing and see the three steps to prepare todayINCYIncyte10/9/2025Boost Price Target$85.38$89.00Neutral$0.0000.00% ROILEGNLegend Biotech10/9/2025Lower Price Target$31.56$76.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Upgrade$68.94$80.00Overweight$0.0000.00% ROIONCBeOne Medicines10/8/2025Boost Price Target$352.25$385.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals10/8/2025Boost Price Target$419.51$530.00Overweight$0.0000.00% ROICRNXCrinetics Pharmaceuticals9/24/2025Lower Price Target$35.86$52.00Overweight$0.0000.00% ROIBNTXBioNTech9/22/2025Boost Price Target$96.22$121.00Neutral$00.0000.00% ROIMIRMMirum Pharmaceuticals9/12/2025Boost Price Target$75.99$77.00Overweight$00.0000.00% ROIALKSAlkermes9/9/2025Boost Price Target$27.87$35.00Neutral$00.0000.00% ROILEGNLegend Biotech8/25/2025Boost Price Target$35.31$78.00Overweight$00.0000.00% ROIIONSIonis Pharmaceuticals8/25/2025Boost Price Target$42.56$49.00Neutral$00.0000.00% ROIINCYIncyte8/22/2025Boost Price Target$85.99$73.00Neutral$000.0000.00% ROIINSMInsmed8/20/2025Boost Price Target$128.94$135.00Overweight$000.0000.00% ROIASNDAscendis Pharma A/S8/19/2025Boost Price Target$194.89$260.00Overweight$000.0000.00% ROIHALOHalozyme Therapeutics8/7/2025Boost Price Target$61.52$63.00Neutral$00.0000.00% ROIALNYAlnylam Pharmaceuticals8/6/2025Boost Price Target$428.14$475.00Overweight$000.0000.00% ROIMRNAModerna8/1/2025Set Price Target$29.56$26.00$00.0000.00% ROIASNDAscendis Pharma A/S7/29/2025Boost Price Target$162.53$254.00Overweight$000.0000.00% ROIONCBeOne Medicines7/17/2025Boost Price Target$288.92$345.00Overweight$000.0000.00% ROIALNYAlnylam Pharmaceuticals7/16/2025Boost Price Target$311.12$348.00Overweight$000.0000.00% ROIHALOHalozyme Therapeutics7/16/2025Boost Price Target$57.91$60.00Neutral$00.0000.00% ROIVRTXVertex Pharmaceuticals7/14/2025Boost Price Target$472.44$517.00Overweight$000.0000.00% ROIINCYIncyte7/14/2025Lower Price Target$69.09$67.00Neutral$000.0000.00% ROIBMRNBioMarin Pharmaceutical7/14/2025Boost Price Target$58.75$113.00Overweight$00.0000.00% ROIINSMInsmed7/8/2025Boost Price Target$96.75$111.00Overweight$000.0000.00% ROIUTHRUnited Therapeutics7/8/2025Lower Price Target$297.61$330.00Overweight$000.0000.00% ROIONCBeOne Medicines6/27/2025Boost Price Target$254.49$321.00Overweight$000.0000.00% ROIIONSIonis Pharmaceuticals6/12/2025Boost Price Target$35.79$48.00Neutral$00.0000.00% ROIALNYAlnylam Pharmaceuticals6/12/2025Boost Price Target$297.32$338.00Overweight$000.0000.00% ROIMRNAModerna5/22/2025Lower Price Target$25.76$26.00Underweight$00.0000.00% ROIBNTXBioNTech5/22/2025Lower Price Target$98.95$116.00Neutral$00.0000.00% ROIVRTXVertex Pharmaceuticals5/6/2025Boost Price Target$443.41$515.00Overweight$000.0000.00% ROIBCRXBioCryst Pharmaceuticals5/6/2025Boost Price Target$10.59$13.00Overweight$0.0000.00% ROIASNDAscendis Pharma A/S5/2/2025Boost Price Target$169.83$245.00Overweight$000.0000.00% ROIUTHRUnited Therapeutics5/1/2025Lower Price Target$296.52$350.00Overweight$000.0000.00% ROIONCBeOne Medicines4/21/2025Boost Price Target$230.64$317.00Overweight$000.0000.00% ROIINCYIncyte4/21/2025Lower Price Target$56.60$68.00Neutral$00.0000.00% ROIHALOHalozyme Therapeutics4/21/2025Boost Price Target$57.24$58.00Neutral$00.0000.00% ROIUTHRUnited Therapeutics4/21/2025Lower Price Target$283.69$355.00Overweight$000.0000.00% ROIIMCRImmunocore4/14/2025Lower Price Target$26.59$50.00Overweight$00.0000.00% ROINVCRNovoCure4/10/2025Lower Price Target$16.14$28.00Neutral$00.0000.00% ROIALNYAlnylam Pharmaceuticals3/24/2025Upgrade$283.34$328.00Overweight$000.0000.00% ROIIONSIonis Pharmaceuticals3/24/2025Lower Price Target$32.91$45.00Neutral$00.0000.00% ROIMRNAModerna3/21/2025Lower Price Target$32.29$33.00Underweight$00.0000.00% ROIASNDAscendis Pharma A/S3/18/2025Boost Price Target$168.84$200.00Overweight$000.0000.00% ROIALNYAlnylam Pharmaceuticals3/11/2025Boost Price Target$236.20$280.00Neutral$000.0000.00% ROIIONSIonis Pharmaceuticals3/11/2025Lower Price Target$31.94$47.00Neutral$00.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Boost Price Target$145.09$209.00Overweight$000.0000.00% ROIMRNAModerna2/14/2025Set Price Target$35.53$45.00$00.0000.00% ROIASNDAscendis Pharma A/S2/13/2025Boost Price Target$145.21$168.00Overweight$000.0000.00% ROIShould You Convert a Traditional IRA to a Roth After 60? (Ad)Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-free qualified withdrawals, and no lifetime required minimum distributions. The catch: converting triggers ordinary income tax in the year you convert, and the decision cannot be reversed. The right move depends on your income, tax bracket, and retirement timeline.Take the free quiz to match with a vetted fiduciary advisor near youINSMInsmed2/7/2025Boost Price Target$79.95$92.00Overweight$000.0000.00% ROIASNDAscendis Pharma A/S1/29/2025Boost Price Target$129.37$167.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuhoStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
